Prescription Required(Save Upto 75%)
Veenat 400mg tablet contains the active substance imatinib. It is an antineoplastic drug that belongs to the class tyrosine kinase inhibitor. It is used in adults, children and adolescents to treat chronic myeloid leukemia (CML) (a form of leukemia in which certain abnormal white cells (named myeloid cells) start growing out of control) and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph-positive ALL) (a form of leukemia in which certain abnormal white cells (named lymphoblasts) start growing out of control).
Veenat 400mg tablet is also used to treat myelodysplastic/myeloproliferative diseases (MDS/MPD); these are a group of blood diseases in which some blood cells start growing out of control. They also treat hyper eosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL); these are blood diseases in which some blood cells (eosinophils) start growing out of control.
This medicine is also intended to treat dermatofibrosarcoma protuberans (DFSP), a cancer of the tissue beneath the skin in which some cells start growing abnormally. It works to inhibit the growth of these abnormal blood cells.
Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.
Treat adults, children and adolescents for:
Treat adults for:
Veenat 400mg tablet is a protein-tyrosine kinase inhibitor that blocks a specific abnormal protein created by a chromosomal abnormality that signals cancer cells to multiply. It inhibits the multiplication and induces cell death in abnormal cancer cells.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine.
Ans :Veenat 400mg tablet is administered orally, in the form of a tablet or capsule, and the dose depends on several factors, including the condition being treated, the weight of the patient, the particular regimen being used, and the overall health of the patient. It should be taken with food and a large glass of water to minimize gastrointestinal irritation.
Ans :This medicine may make your skin much more sensitive to sunlight than it normally is. Exposure to sunlight may cause skin rash, itching, redness, or severe sunburn. When you are outdoors, wear protective clothing and use sunscreen with an SPF. Consult your doctor before taking necessary precautions.
Ans :Yes, when taken for a longer period the medicine may cause damage to your kidneys. Your doctors may recommend you take a routine blood tests to assess your kidney function.
Ans :Take the tablet as prescribed by your doctor. Take Veenat 400mg tablet at the same time every day. It is usually taken with a meal and a large glass of water to avoid stomach problems.
Ans :Memory impairments have been only reported in limited studies. Consult your doctor immediately if you have any trouble in concentrating.
Veenat 400mg tablet contains the active substance imatinib. It is an antineoplastic drug that belongs to the class tyrosine kinase inhibitor. It is used in adults, children and adolescents to treat chronic myeloid leukemia (CML) (a form of leukemia in which certain abnormal white cells (named myeloid cells) start growing out of control) and Philadelphia chromosome positive acute lymphoblastic leukemia (Ph-positive ALL) (a form of leukemia in which certain abnormal white cells (named lymphoblasts) start growing out of control).
Veenat 400mg tablet is also used to treat myelodysplastic/myeloproliferative diseases (MDS/MPD); these are a group of blood diseases in which some blood cells start growing out of control. They also treat hyper eosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL); these are blood diseases in which some blood cells (eosinophils) start growing out of control.
This medicine is also intended to treat dermatofibrosarcoma protuberans (DFSP), a cancer of the tissue beneath the skin in which some cells start growing abnormally. It works to inhibit the growth of these abnormal blood cells.
Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.
Treat adults, children and adolescents for:
Treat adults for:
Veenat 400mg tablet is a protein-tyrosine kinase inhibitor that blocks a specific abnormal protein created by a chromosomal abnormality that signals cancer cells to multiply. It inhibits the multiplication and induces cell death in abnormal cancer cells.
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine.
Ans :Imat 400mg tablet is administered orally, in the form of a tablet or capsule, and the dose depends on several factors, including the condition being treated, the weight of the patient, the particular regimen being used, and the overall health of the patient. It should be taken with food and a large glass of water to minimize gastrointestinal irritation.
Ans :This medicine may make your skin much more sensitive to sunlight than it normally is. Exposure to sunlight may cause skin rash, itching, redness, or severe sunburn. When you are outdoors, wear protective clothing and use sunscreen with an SPF. Consult your doctor before taking necessary precautions.
Ans :Yes, when taken for a longer period the medicine may cause damage to your kidneys. Your doctors may recommend you take a routine blood tests to assess your kidney function.
Ans :Take the tablet as prescribed by your doctor. Take Imat 400mg tablet at the same time every day. It is usually taken with a meal and a large glass of water to avoid stomach problems.
Ans :Memory impairments have been only reported in limited studies. Consult your doctor immediately if you have any trouble in concentrating.
